Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies. Issue 8 (August 2022)

• Record Type: Journal Article
• Authors: Senev, Aleksandar; Lerut, Evelyne; Coemans, Maarten; Callemeyn, Jasper; Copley, Hannah Charlotte; Claas, Frans; Koshy, Priyanka; Kosmoliaptsis, Vasilis; Kuypers, Dirk; Sprangers, Ben; Van Craenenbroeck, Amaryllis; Van Loon, Elisabet; Van Sandt, Vicky; Emonds, Marie-Paule; Naesens, Maarten
• Is Part Of: Clinical journal of the American Society of Nephrology. Volume 17:Issue 8(2022)
• Page Start: 1204
• Page End: 1215
• Publication Date: 2022-08
• Subjects: acute allograft rejection -- immunology -- kidney biopsy -- kidney transplantation -- rejection -- renal biopsy -- renal transplantation -- antibody-mediated rejection -- human leukocyte antigen
• DOI: 10.2215/CJN.00570122
• Languages: English
• ISSNs: 1555-9041

Abstract

Visual Abstract: Abstract : Background and objectives: The histology of antibody-mediated rejection after kidney transplantation is observed frequently in the absence of detectable donor-specific anti-HLA antibodies. Although there is an active interest in the role of non-HLA antibodies in this phenotype, it remains unknown whether HLA mismatches play an antibody-independent role in this phenotype of microcirculation inflammation. Design, setting, participants, & measurements: To study this, we used the tools HLAMatchmaker, three-dimensional electrostatic mismatch score, HLA solvent accessible amino acid mismatches, and mismatched donor HLA–derived T cell epitope targets to determine the degree of HLA molecular mismatches in 893 kidney transplant recipients with available biopsy follow-up. Multivariable Cox proportional hazards models were applied to quantify the cause-specific hazard ratios of the different types of HLA mismatch scores for developing antibody-mediated rejection or histology of antibody-mediated rejection in the absence of donor-specific anti-HLA antibodies. In all survival analyses, the patients were censored at the time of the last biopsy. Results: In total, 121 (14%) patients developed histology of antibody-mediated rejection in the absence of donor-specific anti-HLA antibodies, of which 44 (36%) patients had concomitant T cell–mediated rejection. In multivariable Cox analysis, all different calculations of the degree of HLA mismatch associated with developing histology of antibody-mediated rejection in the absence of donor-specific anti-HLA antibodies. This association was dependent neither on the presence of missing self (potentially related to natural killer cell activation) nor on the formation of de novo HLA antibodies. Also, glomerulitis and complement C4d deposition in peritubular capillaries associated with the degree of HLA mismatch in the absence of anti-HLA antibodies. Conclusions: The histology of antibody-mediated rejection and its defining lesions are also observed in patients without circulating anti-HLA antibodies and relate to the degree of HLA mismatch.